NCT04502030 2025-10-03Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)OctapharmaPhase 3 Completed247 enrolled
NCT03087370 2018-12-07A Retrospective and Prospective Natural History Study of Patients With WHIM SyndromeX4 PharmaceuticalsWithdrawn